Matthew Norkunas

Matthew Norkunas, M.D., M.B.A., currently serves as the chief financial officer of Generation Bio. Prior to Generation Bio, he was chief financial officer at SomaLogic, where he helped lead a complete strategic overhaul for the company, closed several large business development deals, and oversaw strong commercial growth both in the US and overseas. Previously, Matt served as senior equity analyst at Marsico Capital Management, where he was the firm’s primary health-care investment specialist. Matt began his career as a practicing anesthesiologist. He earned a Master of Business Administration from Columbia Business School, a medical degree from University of Maryland School of Medicine, and a Bachelor of Arts degree from St. Mary’s College of Maryland.